Andrew N. Schiff, Director at Aclaris Therapeutics, Inc. (ACRS), bought 217,202 shares at $23.02 ($5.0M) on 2017-08-16, disclosed to the SEC on 2017-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.02 | 108,601 | $2.5M | 50.0% |
| 2 | $23.02 | 108,601 | $2.5M | 50.0% |
| Total | $23.02 avg | 217,202 | $5.0M | 100% |
| Filing → |
| ACRS | SELL | 2022-10-19 | $1.7M | — | Filing → |
| ACRS | SELL | 2022-10-11 | $237K | — | Filing → |
| ACRS | SELL | 2022-10-06 | $1.5M | — | Filing → |